TY - JOUR
T1 - Magnesium sulfate normalizes placental interleukin-6 secretion in preeclampsia
AU - Amash, Alaa
AU - Holcberg, Gershon
AU - Sheiner, Eyal
AU - Huleihel, Mahmoud
PY - 2010/9/1
Y1 - 2010/9/1
N2 - Interleukin-6 (IL-6) is one of the main proinflammatory mediators of hypertension and endothelial dysfunction in preeclampsia. In this study, we investigated the capacity of the preeclamptic placenta to secrete IL-6 and the effect of magnesium sulfate (MgSO4) on it. Placentas from normotensive (37-40 weeks) and preeclamptic (36-40 weeks) pregnancies were dually perfused for 6h in the absence [normotensive (n=3); preeclamptic (n=4)] and presence [normotensive (n=3); preeclamptic (n=4)] of MgSO4. Perfusate samples from the maternal and the fetal circulations were collected at each 30min throughout the perfusion period and examined for IL-6 by enzyme-linked immunoassay. Statistical analysis was performed using the 2-way analysis of variance. In the absence of MgSO4, IL-6 levels in the maternal and the fetal circulations of preeclamptic placentas (4.2±1.3 and 0.9±0.5pg/mL/g cotyledon; respectively) were significantly higher, when compared with normotensive placentas (1.9±0.5 and 0.2±0.2pg/mL/g cotyledon; respectively) (P<0.05). Addition of MgSO4 to the perfusate of normotensive placentas did not affect IL-6 secretion. However, exposure of preeclamptic placentas to MgSO4 resulted in decreased IL-6 levels in the maternal circulations (1.7±0.3pg/mL/g cotyledon), when compared with the control group (P<0.05). In the fetal circulation, the addition of MgSO4 resulted only in a nonstatistical significant tendency toward decreased IL-6 levels, when compared with the control group. Our findings indicate that the perfused preeclamptic placenta secretes increased levels of IL-6 into the fetal and the maternal circulations and that MgSO4 may normalize these increased secreted IL-6 levels.
AB - Interleukin-6 (IL-6) is one of the main proinflammatory mediators of hypertension and endothelial dysfunction in preeclampsia. In this study, we investigated the capacity of the preeclamptic placenta to secrete IL-6 and the effect of magnesium sulfate (MgSO4) on it. Placentas from normotensive (37-40 weeks) and preeclamptic (36-40 weeks) pregnancies were dually perfused for 6h in the absence [normotensive (n=3); preeclamptic (n=4)] and presence [normotensive (n=3); preeclamptic (n=4)] of MgSO4. Perfusate samples from the maternal and the fetal circulations were collected at each 30min throughout the perfusion period and examined for IL-6 by enzyme-linked immunoassay. Statistical analysis was performed using the 2-way analysis of variance. In the absence of MgSO4, IL-6 levels in the maternal and the fetal circulations of preeclamptic placentas (4.2±1.3 and 0.9±0.5pg/mL/g cotyledon; respectively) were significantly higher, when compared with normotensive placentas (1.9±0.5 and 0.2±0.2pg/mL/g cotyledon; respectively) (P<0.05). Addition of MgSO4 to the perfusate of normotensive placentas did not affect IL-6 secretion. However, exposure of preeclamptic placentas to MgSO4 resulted in decreased IL-6 levels in the maternal circulations (1.7±0.3pg/mL/g cotyledon), when compared with the control group (P<0.05). In the fetal circulation, the addition of MgSO4 resulted only in a nonstatistical significant tendency toward decreased IL-6 levels, when compared with the control group. Our findings indicate that the perfused preeclamptic placenta secretes increased levels of IL-6 into the fetal and the maternal circulations and that MgSO4 may normalize these increased secreted IL-6 levels.
UR - http://www.scopus.com/inward/record.url?scp=77956606358&partnerID=8YFLogxK
U2 - 10.1089/jir.2010.0011
DO - 10.1089/jir.2010.0011
M3 - Article
C2 - 20715974
AN - SCOPUS:77956606358
SN - 1079-9907
VL - 30
SP - 683
EP - 690
JO - Journal of Interferon and Cytokine Research
JF - Journal of Interferon and Cytokine Research
IS - 9
ER -